pretickt

When does Biogen report earnings?

Biogen Inc. · end-of-day data as of Nov 13, 2026

Biogen
BIIB · $37.46B
$253.40+1.2%
Nov 13, 2026 · close
$220$240SepOctNov9:3016:003 months +19.2%Nov 13 · close
▲ 4
  • ConsensusBuy · 36
  • Trendbullish
  • MAs4 of 4
  • Sector▲ +15.9%
Neutral
  • Earnings in84d
  • P/E108.3x
  • RSI59
  • Support-10.6%
  • Off 52w high-2.9%
  • Volume0.8x
  • Bollingerupper half
  • News0.00
  • PT$254.56 +0.5%
  • 52w range$160–$261
  • ATR+3.1%
  • Off ATH-47.2%
  • InsidersNone in 90d
▼ 3
  • P/E vs own+148.5%
  • P/E vs sector+236.2%
  • MACD-0.62

Updates with the 15-min delayed price. Not a forecast or investment advice.

Biogen BIIB reports its next earnings on Friday, Feb 5, 2027, before the open, an estimated date the company has not confirmed yet. Analysts expect EPS of $2.81 on revenue of $2.61B. Biogen beat the EPS estimate in 7 of its last 8 reports, and the stock moved ±3.3% on average the session after. The last report, on Oct 28, 2026: EPS of $2.62 against $1.99 expected and revenue of $2.8B against $2.63B; the stock fell 3.4% the next session.

The stock around its reports

⇔⇕$123$164$205$246Nov 24Apr 25Sep 25Feb 26Jul 26Dec 26AAAAEAEEEAAEAAAEAAEAAEAE

Last close $253.40 · +47.3% over 2y · E earnings · D dividend · S split · A analyst rating change

Quarterly results

Q3 FY2026: Revenue +14.2% year over year, free cash flow 21.4% of revenue, operating margin 4.6%.

RevenueFree cash flow
Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Q3 FY2026Sep 30, 2026$2.8B-0.14$600M73.3%4.6%-0.7%
Q2 FY2026Jun 30, 2026$2.74B0.66—56.9%11.6%3.6%
Q1 FY2026Mar 31, 2026$2.48B2.15—73.3%16.0%12.9%
Q4 FY2025Dec 31, 2025$2.28B-0.33—78.2%-2.5%-2.1%
Q3 FY2025Sep 30, 2025$2.45B3.17$1.23B64.3%25.0%19.0%
Q2 FY2025Jun 30, 2025$2.65B4.35$144M64.2%22.2%24.0%
Q1 FY2025Mar 31, 2025$2.43B1.64$212M76.2%30.1%9.9%
Q4 FY2024Dec 31, 2024$2.45B1.83$695M76.2%20.7%10.9%